Metabolic engineering of Escherichia coli to produce a monophosphoryl lipid A adjuvant
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ji, Yuhyun | - |
dc.contributor.author | An, Jinsu | - |
dc.contributor.author | Hwang, Dohyeon | - |
dc.contributor.author | Ha, Da Hui | - |
dc.contributor.author | Lim, Sang Min | - |
dc.contributor.author | Lee, Chankyu | - |
dc.contributor.author | Zhao, Jinshi | - |
dc.contributor.author | Song, Hyun Kyu | - |
dc.contributor.author | Yang, Eun Gyeong | - |
dc.contributor.author | Zhou, Pei | - |
dc.contributor.author | Chung, Hak Suk | - |
dc.date.accessioned | 2021-08-31T15:12:41Z | - |
dc.date.available | 2021-08-31T15:12:41Z | - |
dc.date.created | 2021-06-18 | - |
dc.date.issued | 2020-01 | - |
dc.identifier.issn | 1096-7176 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/58551 | - |
dc.description.abstract | Monophosphoryl lipid A (MPLA) species, including MPL (a trade name of GlaxoSmithKline) and GLA (a trade name of Immune Design, a subsidiary of Merck), are widely used as an adjuvant in vaccines, allergy drugs, and immunotherapy to boost the immune response. Even though MPLA is a derivative of lipopolysaccharide (LPS), a component of the outer membrane of Gram-negative bacteria, bacterial strains producing MPLA have not been found in nature nor engineered. In fact, MPLA generation involves expensive and laborious procedures based on synthetic routes or chemical transformation of precursors isolated from Gram-negative bacteria. Here, we report the engineering of an Escherichia coli strain for in situ production and accumulation of MPLA. Furthermore, we establish a succinct method for purifying MPLA from the engineered E. coli strain. We show that the purified MPLA (named EcML) stimulates the mouse immune system to generate antigen-specific IgG antibodies similarly to commercially available MPLA, but with a dramatically reduced manufacturing time and cost. Our system, employing the first engineered E. coli strain that directly produces the adjuvant EcML, could transform the current standard of industrial MPLA production. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | ACADEMIC PRESS INC ELSEVIER SCIENCE | - |
dc.subject | EFFECTIVE VACCINE | - |
dc.subject | LIPOPOLYSACCHARIDE | - |
dc.subject | 1-PHOSPHATASE | - |
dc.subject | PURIFICATION | - |
dc.subject | EXPRESSION | - |
dc.subject | MEMBRANE | - |
dc.subject | CLONING | - |
dc.subject | MUTANT | - |
dc.subject | LPXE | - |
dc.title | Metabolic engineering of Escherichia coli to produce a monophosphoryl lipid A adjuvant | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Song, Hyun Kyu | - |
dc.identifier.doi | 10.1016/j.ymben.2019.11.009 | - |
dc.identifier.scopusid | 2-s2.0-85076692796 | - |
dc.identifier.wosid | 000506206200019 | - |
dc.identifier.bibliographicCitation | METABOLIC ENGINEERING, v.57, pp.193 - 202 | - |
dc.relation.isPartOf | METABOLIC ENGINEERING | - |
dc.citation.title | METABOLIC ENGINEERING | - |
dc.citation.volume | 57 | - |
dc.citation.startPage | 193 | - |
dc.citation.endPage | 202 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Biotechnology & Applied Microbiology | - |
dc.relation.journalWebOfScienceCategory | Biotechnology & Applied Microbiology | - |
dc.subject.keywordPlus | EFFECTIVE VACCINE | - |
dc.subject.keywordPlus | LIPOPOLYSACCHARIDE | - |
dc.subject.keywordPlus | 1-PHOSPHATASE | - |
dc.subject.keywordPlus | PURIFICATION | - |
dc.subject.keywordPlus | EXPRESSION | - |
dc.subject.keywordPlus | MEMBRANE | - |
dc.subject.keywordPlus | CLONING | - |
dc.subject.keywordPlus | MUTANT | - |
dc.subject.keywordPlus | LPXE | - |
dc.subject.keywordAuthor | Adjuvant | - |
dc.subject.keywordAuthor | Monophosphoryl lipid A | - |
dc.subject.keywordAuthor | Lipopolysaccharide biosynthesis | - |
dc.subject.keywordAuthor | Gram-negative bacterial outer membrane | - |
dc.subject.keywordAuthor | Lipid A 1-phosphatase | - |
dc.subject.keywordAuthor | Vaccine adjuvant | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.